Surprising decision sends weight-loss drug stock reeling
The company has been riding a wave of demand for weight loss drugs.
Doctor, doctor, give me the news, Hims & Hers Health (HIMS) has got bad case of the stock market blues.
The San Francisco telehealth company could've used some strong medicine on March 6 when its shares took sick amid a court ruling and stepped up competition involving weight-loss drugs.
